Navigation Links
MedImmune Advances Asthma Program With Start of Phase 2 Clinical Trial for Antibody Targeting IL-5 Receptor
Date:12/4/2008

ines to patients, new medical options for physicians and rewarding careers to employees. Dedicated to advancing science and medicine to help people live better lives, the company is focused on infection, oncology, respiratory disease and inflammation, cardiovascular/ gastrointestinal disease and neuroscience. Headquartered in Gaithersburg, Maryland, MedImmune has approximately 3,000 employees worldwide and is the wholly owned biologics business for AstraZeneca PLC (LSE: AZN.L, NYSE: AZN). For more information, visit MedImmune's website at http://www.medimmune.com.


'/>"/>
SOURCE MedImmune
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. MedImmune Announces Zook as President
2. MedImmune Presents Data Highlighting its Progressive Inflammatory Disease Portfolio at the 72nd Annual Meeting of the American College of Rheumatology
3. MedImmune Licenses Reverse Genetics Technology to Hungarys Omninvest for Use in Influenza Vaccine Development and Production
4. MedImmune Expands R&D Capacity with New Research Facility in Cambridge, U.K.
5. MedImmune Presents Data at AAP National Conference & Exhibition Demonstrating Burden of RSV Disease
6. Pinnacle Biologics Announces Stock Purchase Agreement With MedImmune
7. MedImmunes Brian Rosen Honored by Montgomery County Chamber at 49th Annual Awards Dinner
8. Depth of MedImmunes Respiratory Disease Research Program Highlighted at Annual Meeting of the American Thoracic Society
9. MedImmune Fortifies Strategic Scientific Portfolio Management and International Leadership With New Executive Appointments
10. MedImmune Presents Data Highlighting its Progressive Oncology Portfolio at Annual Meeting of the American Association For Cancer Research
11. Seneca Valley High School Student Receives Science Award From MedImmune
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Biology News(10 mins):Studying hair of ancient Peruvians answers questions about stress 2BIO-key(R) Selected as 2009 Industry Innovator in Biometrics by SC Magazine 2BIO-key(R) Selected as 2009 Industry Innovator in Biometrics by SC Magazine 3ADA releases updated position paper on nutrient supplementation 2Data From Multiple Clinical Trials of OrbusNeichs Genous 28TM 29 Bio engineered R stent 28TM 29 to be Presented at TCT 2009 5003 1Data From Multiple Clinical Trials of OrbusNeichs Genous 28TM 29 Bio engineered R stent 28TM 29 to be Presented at TCT 2009 5003 2Data From Multiple Clinical Trials of OrbusNeichs Genous 28TM 29 Bio engineered R stent 28TM 29 to be Presented at TCT 2009 5003 3Frost 26 Sullivan 3A First Responders Communication Interoperability A Vital Need for Life Saving Services 57146 1Frost 26 Sullivan 3A First Responders Communication Interoperability A Vital Need for Life Saving Services 57146 2The MedZilla Report for August 2009 Health Care Grows Another 28 000 While Hospitals And Insurers Feel Painful Pinch 14042 1The MedZilla Report for August 2009 Health Care Grows Another 28 000 While Hospitals And Insurers Feel Painful Pinch 14042 2The MedZilla Report for August 2009 Health Care Grows Another 28 000 While Hospitals And Insurers Feel Painful Pinch 14042 3The MedZilla Report for August 2009 Health Care Grows Another 28 000 While Hospitals And Insurers Feel Painful Pinch 14042 4